Medical/Pharmaceuticals
Licensing Partner of Shenzhen Chipscreen Biosciences - HUYABIO International, Receives Regulatory Approval for Chidamide Monotherapy of Adult T-cell Leukemia/lymphoma in Japan
SHENZHEN, China, June 24, 2021 /PRNewswire/ -- Shenzhen Chipscreen Biosciences' licensing partner, HUYABIO International (HUYABIO™), today announced the regulatory approval for Tucidinostat (also known as Chidamide, Epidaza ®, HBI-8000) monotherapy of relapsed or refractory (R/R) adult T-cell le...
2021-06-24 19:00
3845
Advanced Aesthetic Technologies, Inc. Announces the Treatment of the First Patient in a Pivotal Clinical Trial in China with their Algeness® VL (2.5% Agarose Gel) Filler for the Correction of Moderate to Severe Nasolabial Folds
This new clinical trial is being conducted through their partnership with Lanzhou Biotechnique Development Co., LTD (LanDev) and their parent company China National Biotec Group Co., LTD (CNBG) and will be used to seek marketing approval inChina BROOKLINE, Mass., June 24, 2021 /PRNewswire/ -- Ad...
2021-06-24 18:00
3101
Boan Biotech Publishes Research Results for CEA/CD3 Bispecific Antibody in Antibody Therapeutics
BOSTON, June 24, 2021 /PRNewswire/ -- Luye Pharma Group's subsidiary Boan
Biotech recently published research results for its innovative in-house
bispecific antibody BA1202 (CEA/CD3 bispecific T-cell engager) inAntibody
Therapeutics.
2021-06-24 14:49
4223
China's first CAR-T Cell Therapy approved-Fosun Kite Axicabtagene Ciloleucel (FKC876)
* The first* CAR-T cell therapy approved by NMPA: opening a new era of cell therapy inChina * Individualized living-cell-based medicine: genetically modify patient's T-cells to expresses a chimeric antigen receptor (CAR) that will activate T-cells upon engaging cells carrying the specific ant...
2021-06-24 14:46
2938
CStone announces positive GAVRETO® (pralsetinib) registrational study data for first-line treatment of advanced RET fusion-positive non-small cell lung cancer and plans to submit a new indication application
* Key efficacy data showed that GAVRETO demonstrated deep and durable clinical activity in Chinese patients with RET fusion-positive non-small cell lung cancer (NSCLC) * CStone plans to submit new indication application to the China National Medical Products Administration for GAVRETO as a fi...
2021-06-24 08:05
7560
Endurance RP Limited: A New Name, A New Perspective Eye on China's fertility and longevity market
HONG KONG, June 23, 2021 /PRNewswire/ -- Endurance RP Limited ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) is pleased to announce the official completion of the rebranding of the Group, with the Company name changed to "Endurance RP...
2021-06-23 22:33
16480
Alterity Therapeutics Limited Received European Union Regulatory Guidance for ATH434 Phase 2 Clinical Trial
Highlights: * Alterity receives positive guidance from the European Medicines Agency's Committee for Medicinal Products for Human Use on its Phase 2 clinical trial for Multiple System Atrophy. * Concurrence with Alterity's plan to target early stage MSA patients. * Endorsement on selection ...
2021-06-23 21:21
15590
Over a year into the global pandemic, Samsung Biologics continues to leverage innovative virtual platform for remote audits and regulatory inspections
* Samsung Biologics' Live Virtual Tour (LVT) used in one of the earliest FDA full virtual assessments * Recently hosted EMA for 6 PAIs simultaneously using LVT INCHEON, South Korea ,June 23, 2021 /PRNewswire/ -- Samsung Biologics, a global contract development and manufacturing organization (C...
2021-06-23 19:28
1941
IMPRESSION - A randomised trial to evaluate the efficacy of MagicTouch Sirolimus Coated Balloon in Dysfunctional Fistula progresses rapidly
SINGAPORE, June 23, 2021 /PRNewswire/ -- Concept Medical Inc.,
2021-06-23 19:02
3414
Senhwa Announces IND Submission to India's CDSCO of a Phase II Clinical Study for Silmitasertib as a Potential COVID-19 Treatment
TAIPEI and SAN DIEGO, June 23, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on developing first-in-class therapeutics for the treatment of cancer, rare conditions, and novel coronaviruses, today announced that it has submitted an I...
2021-06-23 19:00
1952
Biocytogen Completes a New Round of Financing Totaling Tens of Millions of Dollars
BEIJING, June 23, 2021 /PRNewswire/ -- Biocytogen
2021-06-23 17:02
3201
Envirotainer Welcomes Qatar Airways Cargo as the latest airline to approve the new Releye® RLP
STOCKHOLM, June 23, 2021 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, today announced that Qatar Airways Cargo has approved the Envirotainer Releye® RLP container for their fleet of aircraft. With this approval, t...
2021-06-23 16:55
1996
Clinical Application of Lunit AI For Chest Radiography and Mammography to Be Presented at AOCR 2021
* Two South Korean radiologists share benefits and feedback of using AI products for chest x-rays and mammograms in an actual patient care * Company expects to deliver the diagnostic value of AI and expand its implementation across clinical sites in theAsia-Pacific region SEOUL, June 23, 2021...
2021-06-23 10:28
3484
Sintilimab in Combination with Chemotherapy Meets Overall Survival Primary Endpoint in the Global Phase 3 ORIENT-15 Study for the First-Line Treatment of Esophageal Squamous Cell Carcinoma
SAN FRANCISCO and SUZHOU, China, June 23, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...
2021-06-23 09:16
21335
Biocytogen Completes a New Round of Financing Totaling Tens of Millions of Dollars
BEIJING and BOSTON, June 22, 2021 /PRNewswire/ -- Biocytogen, an international biotechnology company focused on antibody drug research and development (R&D) using innovative genetically engineered animal models, today announced the successful completion of a new round of financing totaling tens o...
2021-06-23 04:16
2053
Mina J. Bissell Ph.D. & Vectorspace AI Advance New Space Biosciences Division
SAN FRANCISCO, June 23, 2021 /PRNewswire/ -- As the new space race heats up, more humans will be traveling into space than ever before. Spaceflight causes many changes in human health. Humans cannot be sent into space without understanding how to protect and repair human DNA along with tissue re...
2021-06-23 03:16
1938
Global Water Scarcity and Hospitalization Rates Stimulate the Polymeric Membranes Market
The demand for water treatment membranes and medical membranes will drive the global market, says Frost & Sullivan SANTA CLARA, Calif., June 23, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis of the global polymeric membranes market finds that the drive to achieve a circular economy and...
2021-06-23 00:14
2499
Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia
SHENZHEN, China, June 22, 2021 /PRNewswire/ -- On June 21, local time, phase III clinical fieldwork of the Inactivated COVID-19 Vaccine (Vero cells) independently developed and manufactured by Shenzhen Kangtai Biological Products Co., Ltd. was officially initiated inMalaysia, and the first batch ...
2021-06-22 22:32
10206
Insilico Medicine Raises $255 Million in Series C Financing Led by Warburg Pincus
NEW YORK and HONG KONG, June 22, 2021 /PRNewswire/ -- Insilico Medicine, a global leader in end-to-end artificial intelligence for target discovery, small molecule chemistry, and clinical development, announced that it has closed a $255 million Series C financing led by Warburg Pincus. The financi...
2021-06-22 21:46
4794
Eurofins Discovery and ImmunoPrecise Announce Collaboration to Expand their Antibody Discovery Platform
ST. CHARLES, Mo., June 22, 2021 /PRNewswire/ -- Eurofins Discovery, the leading provider of products and services to the drug discovery industry and a Eurofins Scientific (EUFI.PA) company, and ImmunoPrecise Antibodies (Nasdaq:IPA), the market leader in full-service therapeutic discovery and deve...
2021-06-22 20:28
6092
Week's Top Stories
Most Reposted
Visa and Trip.com Group Ink Strategic Collaboration, Enabling Consumers to Chase Their Passions Through Travel
[Picked up by 308 media titles]
2026-05-19 18:10
Two-day Global Prosperity Summit 2026 officially opens
[Picked up by 307 media titles]
2026-05-19 23:59
Hong Leong Bank Awarded Best Managed Bank in Malaysia by The Asian Banker, Group MD/CEO Kevin Lam Named Best Bank CEO in Malaysia
[Picked up by 293 media titles]
2026-05-15 17:00
Hyundai Motor Group to Pioneer Hong Kong's Hydrogen Economy, Accelerating Asia-Pacific Expansion
[Picked up by 289 media titles]
2026-05-18 15:30
AIMX Singapore 2026 Anchors Strategic Relationship with TechInnovation and AI Gravity
[Picked up by 279 media titles]
2026-05-19 14:00
Most Read
H World Group Reports Q1 Results, Highlighting Asset-light Growth and Expanding APAC Footprint
2026-05-15 20:11
8023
